Effects of intracerebroventricular β-funaltrexamine on μ and δ opioid receptors in the rat: dichotomy between binding and antinociception
- 15 October 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 203 (2) , 195-202
- https://doi.org/10.1016/0014-2999(91)90715-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Alkylation with β‐funaltrexamine suggests differences between μ‐opioid receptor systems in guinea‐pig brain and myenteric‐plexusBritish Journal of Pharmacology, 1991
- Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphinePharmacology Biochemistry and Behavior, 1991
- Nicotine protects against μ-opioid receptor antagonism by β-funaltrexamine: Evidence for nicotine-induced release of endogenous opioids in brainNeuroscience Letters, 1990
- Mu-type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to guanine nucleotide binding proteinsBrain Research, 1989
- The physiological relevance of low agonist affinity binding at opioid μ-receptorsBritish Journal of Pharmacology, 1988
- Effects of stress and β-funal trexamine pretreatment on morphine analgesia and opioid binding in ratsLife Sciences, 1987
- Reversal by β‐funaltrexamine of the antinociceptive effect of opioid agonists in the ratBritish Journal of Pharmacology, 1986
- Determination of the receptor selectivity of opioid agonists in the guinea‐pig ileum and mouse vas deferens by use of β‐funaltrexamineBritish Journal of Pharmacology, 1985
- Pre-incubation of guinea-pig myenteric plexus with β-funaltrexamine: discrepancy between binding assays and bioassaysBritish Journal of Pharmacology, 1985
- Prolonged antagonism of central Mu- and delta-opioid receptor activity by β-funaltrexamineLife Sciences, 1985